{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:47:40Z","timestamp":1788562060343,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.euo.2024.01.012","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T21:14:43Z","timestamp":1706649283000},"page":"1327-1337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non\u2013muscle-invasive Bladder Cancer"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8221-4640","authenticated-orcid":false,"given":"Paramananthan","family":"Mariappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Trail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Hollins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barend A.","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Garau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Guerrero","family":"Enriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair","family":"Boden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altaf H.","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaimin R.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam M.","family":"Nandwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Dimitropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Makaroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnstone","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hendry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2024.01.012_b0005","series-title":"Bladder cancer treatment (PDQ(R)): health professional version. PDQ cancer information summaries","author":"NIH","year":"2002"},{"key":"10.1016\/j.euo.2024.01.012_b0010","series-title":"Ensuring quality cancer care","year":"1999"},{"key":"10.1016\/j.euo.2024.01.012_b0015","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1016\/j.clgc.2019.12.004","article-title":"Effects of bladder cancer on UK healthcare costs and patient health-related quality of life: evidence from the BOXIT trial","volume":"18","author":"Cox","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euo.2024.01.012_b0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.eururo.2021.01.032","article-title":"Quality of life after bladder cancer: a cross-sectional survey of patient-reported outcomes","volume":"79","author":"Catto","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.012_b0025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrurol.2016.165","article-title":"Bladder cancer: low adherence to guidelines in non-muscle-invasive disease","volume":"13","author":"van Rhijn","year":"2016","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2024.01.012_b0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clon.2020.07.001","article-title":"Failing to close the gap between evidence and clinical practice in radical bladder cancer radiotherapy","volume":"33","author":"Hafeez","year":"2021","journal-title":"Clin Oncol"},{"key":"10.1016\/j.euo.2024.01.012_b0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/bju.15336","article-title":"What influences adherence to guidance for postoperative instillation of intravesical chemotherapy to patients with bladder cancer?","volume":"128","author":"Dunsmore","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2024.01.012_b0040","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0302-2838(02)00068-4","article-title":"Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies","volume":"41","author":"Brausi","year":"2002","journal-title":"Eur Urol"},{"issue":"2 Pt 1","key":"10.1016\/j.euo.2024.01.012_b0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.ju.0000070437.14275.e0","article-title":"Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study","volume":"170","author":"Grimm","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2024.01.012_b0050","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/bju.13383","article-title":"EAU Guidelines Office \u2018IMAGINE\u2019 Project. European Association of Urology (EAU) guidelines: do we care? Reflections from the EAU Impact Assessment of Guidelines Implementation and Education Group","volume":"117","author":"Briganti","year":"2016","journal-title":"BJU Int"},{"issue":"3 Suppl","key":"10.1016\/j.euo.2024.01.012_b0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2307\/3348969","article-title":"Evaluating the quality of medical care","volume":"44","author":"Donabedian","year":"1966","journal-title":"Milbank Mem Fund Q"},{"key":"10.1016\/j.euo.2024.01.012_b0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000319369","article-title":"Quality of care indicators for muscle-invasive bladder cancer","volume":"86","author":"Goossens-Laan","year":"2011","journal-title":"Urol Int"},{"key":"10.1016\/j.euo.2024.01.012_b0065","doi-asserted-by":"crossref","first-page":"e784","DOI":"10.1016\/j.clgc.2019.04.014","article-title":"Quality control indicators for transurethral resection of non-muscle-invasive bladder cancer","volume":"17","author":"Akand","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euo.2024.01.012_b0070","unstructured":"NHS, Scotland Better cancer care, an action plan. Edinburg, Scotland Edinburgh, Scotland: The Scottish Government; 2008. Better Cancer Care, An Action Plan - gov.scot (www.gov.scot)."},{"key":"10.1016\/j.euo.2024.01.012_b0075","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.euf.2021.07.011","article-title":"The Scottish Bladder Cancer Quality Performance Indicators Influencing Outcomes, Prognosis, and Surveillance (Scot BC Quality OPS) clinical project","volume":"7","author":"Mariappan","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2024.01.012_b0080","unstructured":"Healthcare Improvement Scotland. Bladder cancer clinical quality performance indicators. 2014. http:\/\/www.healthcareimprovementscotland.org\/his\/idoc.ashx?docid=1d5bd547-316d-49b0-8948-e2aed407a660&version=-1."},{"key":"10.1016\/j.euo.2024.01.012_b0085","series-title":"Dataset for tumours of the urinary collecting system (renal pelvis, ureter, urinary bladder and urethra)","author":"Shanks","year":"2013"},{"key":"10.1016\/j.euo.2024.01.012_b0090","unstructured":"Information Services Division, NHS National Services Scotland. Bladder cancer quality performance indicators: patients diagnosed between April 2014 and March 2017. 2018. https:\/\/www.isdscotland.org\/Health-Topics\/Quality-Indicators\/Publications\/2018-08-28\/2018-08-28-Bladder-QPI-Report.pdf?774782897."},{"key":"10.1016\/j.euo.2024.01.012_b0095","unstructured":"What are the T0 to T4 classifications? [Classification of translational research]. ICTR. https:\/\/ictr.wisc.edu\/what-are-the-t0-to-t4-research-classifications\/."},{"key":"10.1016\/j.euo.2024.01.012_b0100","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.012_b0105","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2020.06.051","article-title":"Enhanced quality and effectiveness of transurethral resection of bladder tumour in non-muscle-invasive bladder cancer: a multicentre real-world experience from Scotland's Quality Performance Indicators Programme","volume":"78","author":"Mariappan","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.012_b0110","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","article-title":"Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience","volume":"57","author":"Mariappan","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.012_b0115","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1464-410X.2011.10571.x","volume":"109","author":"Mariappan","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2024.01.012_b0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"Sylvester","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.012_b0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.urology.2015.04.015","article-title":"Real-life experience: early recurrence with Hexvix photodynamic diagnosis-assisted transurethral resection of bladder tumour vs good-quality white light TURBT in new non-muscle-invasive bladder cancer","volume":"86","author":"Mariappan","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.euo.2024.01.012_b0130","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00345-017-2077-6","article-title":"'Real-life experience': recurrence rate at 3 years with Hexvix((R)) photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC\u2014a prospective controlled study","volume":"35","author":"Gallagher","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2024.01.012_b0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1748-5908-7-38","article-title":"Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the Theoretical Domains Framework","volume":"7","author":"French","year":"2012","journal-title":"Implement Sci"},{"key":"10.1016\/j.euo.2024.01.012_b0140","unstructured":"The Health Foundation. Evidence scan: the impact of performance targets within the NHS and internationally. 2015. http:\/\/www.health.org.uk\/sites\/default\/files\/TheImpactOfPerformanceTargetsWithinTheNHSAndInternationally_0.pdf."},{"key":"10.1016\/j.euo.2024.01.012_b0145","doi-asserted-by":"crossref","first-page":"40.e17","DOI":"10.1016\/j.urolonc.2013.04.009","article-title":"Presence of detrusor muscle in bladder tumor specimens\u2014predictors and effect on outcome as a measure of resection quality","volume":"32","author":"Shoshany","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2024.01.012_b0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.urology.2017.08.007","article-title":"Predicting grade and stage at cystoscopy in newly presenting bladder cancers\u2014a prospective double-blind clinical study","volume":"109","author":"Mariappan","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.euo.2024.01.012_b0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/qhc.11.4.358","article-title":"Research methods used in developing and applying quality indicators in primary care","volume":"11","author":"Campbell","year":"2002","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.euo.2024.01.012_b0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/qshc.2004.011155","article-title":"Making psychological theory useful for implementing evidence based practice: a consensus approach","volume":"14","author":"Michie","year":"2005","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.euo.2024.01.012_b0165","series-title":"The behavioural change wheel: a guide to designing interventions","author":"Michie","year":"2014"},{"key":"10.1016\/j.euo.2024.01.012_b0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"},{"key":"10.1016\/j.euo.2024.01.012_b0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eururo.2019.09.001","article-title":"Quality indicators for bladder cancer services: a collaborative review","volume":"78","author":"Leow","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.012_b0180","doi-asserted-by":"crossref","first-page":"492","DOI":"10.6004\/jnccn.2013.0061","article-title":"Quality indicators in the management of bladder cancer","volume":"11","author":"Montgomery","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.euo.2024.01.012_b0185","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.urolonc.2016.12.003","article-title":"Quality indicators in the management of bladder cancer: a modified Delphi study","volume":"35","author":"Khare","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2024.01.012_b0190","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1200\/JCO.2014.55.4741","article-title":"Strategies to help oncologists deliver high-quality care","volume":"32","author":"Haines","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2024.01.012_b0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JOP.2013.001369","article-title":"Institute of Medicine report on delivery of high-quality cancer care","volume":"10","author":"Ganz","year":"2014","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.euo.2024.01.012_b0200","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1200\/JCO.2015.64.4070","article-title":"Definitions, end points, and clinical trial designs for non-muscle-invasive bladder cancer: recommendations from the International Bladder Cancer Group","volume":"34","author":"Kamat","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2024.01.012_b0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41585-021-00441-9","article-title":"Attention to detail and a permissive set-up: crucial for an effective TURBT","volume":"18","author":"Mariappan","year":"2021","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2024.01.012_b0210","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931124000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931124000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T19:10:55Z","timestamp":1737832255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931124000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2588931124000373"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2024.01.012","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non\u2013muscle-invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2024.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}